Abstracts

Search by keyword or author name.

Showing 852 abstracts.

Shaffiq M. Essajee, Ram Yogev, M.D., Henry Pollack, M.D., B. Greenhouse, Keith Krasinski, M.D., William Borkowsky, M.D. Viral Genotypic Responses to Recombinant Vaccine Therapy in HIV-1 Infected Children.
Sandra K. Burchett, M.D., M.S., Margaret Khoury, M.D., Kenneth McIntosh, M.D., S. V. Carey, Rebecca Oyomopito, M.S., Lynne M. Mofenson, M.D., F.A.A.P., Elizabeth (Betsy) Smith, M.D., Andrea Kovacs, M.D. Viral Load Reduction (VLR) In HIV-Infected Children With Advanced Disease Treated With 4-Drug ARV Regimens Including NRTIs, Nevirapine (NVP), Nelfinavir (NFV), and/or Ritonavir (RTV).
G. M. Ellis, William Borkowsky, M.D., Ram Yogev, M.D., Bonnie J. Ank, Petronella Muresan, M.S., Terence Fenton, Ed.D., Barbara E. Heckman, B.S., Elizabeth (Betsy) J. McFarland, M.D., Edmund Capparelli, Pharm.D., John ( Jack ) Moye, Jr., M.D., Shirley Jankelevich, M.D., Lisa M. Frenkel, M.D. Viral populations with distinct drug-resistant genotypes shift during repeated STI.

Study

P1015
Sandra K. Burchett, M.D., M.S., Vincent J. Carey, Ph.D., Florence H. Yong, M.S., John L. Sullivan, M.D., Steven Sulzbacher, Ph.D., Lucy Civitello, M.D., Mary Culnane, C.R.N.P., M.S., Lynne M. Mofenson, M.D., F.A.A.P., Suzanne Siminski, M.S., M.B.A., Patrick Robinson, M.D., Katherine Luzuriaga, M.D. Virologic Activity Of Didanosine (DDL), Zidovudine (ZDV) and Nevirapine (NVP) Combinations In Pediatric Subjects With Advanced Disease.
Ram Yogev, M.D., William Borkowsky, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., Elizabeth (Betsy) J. McFarland, M.D., Lisa M. Frenkel, M.D., Edmund Capparelli, Pharm.D., Barbara E. Heckman, B.S., John ( Jack ) Moye, Jr., M.D., Shirley Jankelevich, M.D. Virologic and Clinical Outcomes of a Progressively Increasing Structured Treatment Interruption Study in Chronically-infected Children.

Study

P1015
Adriana Weinberg, M.D., Paula Britto, M.S., ChengCheng Hu, Ph.D., Ruth E. Dickover, Ph.D., Mobeen H. Rathore, M.D., Ross E. McKinney, Jr., M.D. Virologic and immunologic correlates of immune reconstitution in HIV-infected children on FTC/DDI/EFV: PACTG protocol P1021. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Conference

13th Conference on Retroviruses and Opportunistic Infections

Study

P1021
Virologic and immunologic outcomes and adherence in adolescents initiating HAART: 3-year follow-up data from PACTG 381. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Conference

13th Conference on Retroviruses and Opportunistic Infections
Andrea Kovacs, M.D., Sandra K. Burchett, M.D., M.S., Margaret Khoury, M.D., Vincent J. Carey, Ph.D., Savita G. Pahwa, M.D., Kenneth McIntosh, M.D., Rebecca Oyomopito, M.S., Elizabeth (Betsy) Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P. Virologic and immunologic responses in children with advanced HIV disease on a new HAART regimen (PACTG 366). Presented at: 8th Conference on Retroviruses & Opportunistic Infections.

Conference

8th Conference on Retroviruses & Opportunistic Infections
Ram Yogev, M.D., Kenneth Stanley, Ph.D., Sharon Appelbaum Nachman, M.D., Stephen Ira Pelton, M.D., Kenneth McIntosh, M.D., Andrew A. Wiznia, M.D. Virologic Efficacy Of ZDV+3TC vs d4T+Ritonavir (RTV) vs ZDV+3TC+RTV In Stable Antiretroviral Experienced HIV-Infected Children (Pediatric ACTG 338).
Ram Yogev, M.D. Virologic Efficacy of ZDV+3TC vs. d4T+Ritonavir vs. ZDV+3TC+RTV in Stable Antiretroviral Experienced HIV-infected Children (PACTG Trial 338).